Herbal Technological Prospects of Morus nigra L.: A Systematic Patent Analysis Review.

Q3 Biochemistry, Genetics and Molecular Biology
Larissa Pereira Alves, Widson Michael Dos Santos, Myla Lôbo de Souza, Larissa Araújo Rolim, Pedro José Rolim-Neto
{"title":"Herbal Technological Prospects of <i>Morus nigra</i> L.: A Systematic Patent Analysis Review.","authors":"Larissa Pereira Alves, Widson Michael Dos Santos, Myla Lôbo de Souza, Larissa Araújo Rolim, Pedro José Rolim-Neto","doi":"10.2174/1872208317666230821102411","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Morus nigra</i> L. is a plant with significant potential for drug development due to the presence of numerous bioactive compounds in its various parts.</p><p><strong>Objectives: </strong>This article aims to compile the technological perspectives of <i>Morus nigra</i> L. towards drug development and therapeutic indications based on registered patents in databases.</p><p><strong>Methods: </strong>The study analyzed patents published within the last five years, focusing on products derived from different parts of the <i>Morus nigra</i> L. plant. Patent databases such as the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), the World Intellectual Property Organization (WIPO), and the National Institute of Industrial Property Databases (INPI) were examined.</p><p><strong>Results: </strong>A total of 45 patents were categorized by country of origin, type of applicant, extraction method, and therapeutic indications. China had the highest number of patent filings (43.48%), and private companies were the primary technology patent holders (38.64%). Noteworthy extraction methods included ultrasound-assisted extraction, decoction, infusion, and maceration. The most utilized plant parts were leaves (44.44%), followed by fruits (35.56%), root bark (15.56%), and stems (4.44%). The main therapeutic indications identified were the treatment of hyperglycemia and dyslipidemia (43.33%), along with digestive problems, cosmetics, nutrition, and cleaning applications.</p><p><strong>Conclusion: </strong>The study of patents covers discoveries and advancements often absent in scientific articles, making a review focused on this advanced information crucial for expanding existing scientific knowledge. Even if some therapies have been explored previously, patents can reveal innovative approaches and fresh perspectives that contribute to sustained scientific progress.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872208317666230821102411","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Morus nigra L. is a plant with significant potential for drug development due to the presence of numerous bioactive compounds in its various parts.

Objectives: This article aims to compile the technological perspectives of Morus nigra L. towards drug development and therapeutic indications based on registered patents in databases.

Methods: The study analyzed patents published within the last five years, focusing on products derived from different parts of the Morus nigra L. plant. Patent databases such as the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), the World Intellectual Property Organization (WIPO), and the National Institute of Industrial Property Databases (INPI) were examined.

Results: A total of 45 patents were categorized by country of origin, type of applicant, extraction method, and therapeutic indications. China had the highest number of patent filings (43.48%), and private companies were the primary technology patent holders (38.64%). Noteworthy extraction methods included ultrasound-assisted extraction, decoction, infusion, and maceration. The most utilized plant parts were leaves (44.44%), followed by fruits (35.56%), root bark (15.56%), and stems (4.44%). The main therapeutic indications identified were the treatment of hyperglycemia and dyslipidemia (43.33%), along with digestive problems, cosmetics, nutrition, and cleaning applications.

Conclusion: The study of patents covers discoveries and advancements often absent in scientific articles, making a review focused on this advanced information crucial for expanding existing scientific knowledge. Even if some therapies have been explored previously, patents can reveal innovative approaches and fresh perspectives that contribute to sustained scientific progress.

黑桑树的草药技术前景:系统专利分析综述。
背景:黑桑树(Morus nigra L.)是一种具有药物开发巨大潜力的植物,因为它的各个部分含有大量生物活性化合物:本文旨在根据数据库中的注册专利,梳理黑桑树在药物开发和治疗适应症方面的技术前景:研究分析了过去五年内公布的专利,重点关注从黑桑树不同部位提取的产品。研究考察了欧洲专利局(EPO)、美国专利商标局(USPTO)、世界知识产权组织(WIPO)和国家工业产权数据库研究所(INPI)等专利数据库:共有 45 项专利按原产国、申请人类型、提取方法和治疗适应症进行了分类。中国的专利申请数量最多(43.48%),私营公司是主要的技术专利持有者(38.64%)。值得注意的提取方法包括超声辅助提取、煎煮、浸泡和浸渍。使用最多的植物部位是叶(44.44%),其次是果(35.56%)、根皮(15.56%)和茎(4.44%)。已确定的主要治疗适应症是治疗高血糖和血脂异常(43.33%),以及消化问题、化妆品、营养和清洁应用:专利研究涵盖了科学文章中通常没有的发现和进展,因此,以这些先进信息为重点的综述对于扩展现有科学知识至关重要。即使某些疗法以前已经被探索过,专利也能揭示创新的方法和新的视角,从而促进科学的持续进步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Recent patents on biotechnology
Recent patents on biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
2.90
自引率
0.00%
发文量
51
期刊介绍: Recent Patents on Biotechnology publishes review articles by experts on recent patents on biotechnology. A selection of important and recent patents on biotechnology is also included in the journal. The journal is essential reading for all researchers involved in all fields of biotechnology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信